Biogen Inc. (BIIB)
BIIB price $240.98 -2.12 -0.87%
- Ticker
- BIIB
- Price
- $240.98
- Change
- -2.12 -0.87%
- Market cap
- $35.61B
- P/E
- 42.43
- Forward P/E
- 19.50
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 38
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while…